November 5, 2004

Larry Weisenthal, MD, PhD
Weisenthal Cancer Group
15140 Transistor Lane
Huntington Beach, CA  92649

Dear Dr. Weisenthal:

We have reviewed your letter to the editor, titled "Journal of
Clinical Oncology Reviews on Cell Culture Drug Resistance Testing
(CCDRT)" (LTE 345-04).  I regret to inform you that your letter is not
acceptable for publication in the Journal of Clinical Oncology.

Thank you for giving us the opportunity to consider your letter to the
editor for the Journal of Clinical Oncology.

Sincerely,

Daniel G. Haller, MD
Editor-in-Chief
hallerd@asco.org